HCT for CGD? Yes, and the sooner the better

2Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this edition of Blood, Chiesa et al have described excellent outcomes after allogeneic hematopoietic cell transplantation (allo-HCT) for 712 patients with chronic granulomatous disease (CGD). This study reports the largest published cohort to date by a significant margin.1

Cite

CITATION STYLE

APA

Morris, E. C. (2020). HCT for CGD? Yes, and the sooner the better. Blood, 136(10), 1121–1123. https://doi.org/10.1182/blood.2020007891

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free